Compare VVOS & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VVOS | RGNT |
|---|---|---|
| Founded | 2016 | 2004 |
| Country | United States | |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4M | 20.4M |
| IPO Year | 2020 | N/A |
| Metric | VVOS | RGNT |
|---|---|---|
| Price | $1.62 | $3.91 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.25 | N/A |
| AVG Volume (30 Days) | ★ 124.1K | 12.5K |
| Earning Date | 02-23-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,031,000.00 | N/A |
| Revenue This Year | $28.86 | N/A |
| Revenue Next Year | $48.70 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.91 | N/A |
| 52 Week Low | $1.42 | $3.91 |
| 52 Week High | $7.40 | $8.35 |
| Indicator | VVOS | RGNT |
|---|---|---|
| Relative Strength Index (RSI) | 44.03 | 24.84 |
| Support Level | $1.46 | $3.91 |
| Resistance Level | $1.67 | $4.64 |
| Average True Range (ATR) | 0.13 | 0.38 |
| MACD | 0.02 | -0.13 |
| Stochastic Oscillator | 45.24 | 4.05 |
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate (a polymer involved in tissue engineering) and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.